Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two Phase 3 international trials in comparison with radionuclide perfusion imaging.

MLA

Senior R, et al. “Detection of Coronary Artery Disease with Perfusion Stress Echocardiography Using a Novel Ultrasound Imaging Agent: Two Phase 3 International Trials in Comparison with Radionuclide Perfusion Imaging.” European Journal of Echocardiography, vol. 10, no. 1, Jan. 2009, pp. 26–35. EBSCOhost, https://doi.org/10.1093/ejechocard/jen321.

APA

Senior R, Monaghan M, Main ML, Zamorano JL, Tiemann K, Agati L, Weissman NJ, Klein AL, Marwick TH, Ahmad M, DeMaria AN, Zabalgoitia M, Becher H, Kaul S, Udelson JE, Wackers FJ, Walovitch RC, Picard MH, & RAMP-1 and RAMP-2 Investigators. (2009). Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two Phase 3 international trials in comparison with radionuclide perfusion imaging. European Journal of Echocardiography, 10(1), 26–35. https://doi.org/10.1093/ejechocard/jen321

Chicago

Senior R, Monaghan M, Main ML, Zamorano JL, Tiemann K, Agati L, Weissman NJ, et al. 2009. “Detection of Coronary Artery Disease with Perfusion Stress Echocardiography Using a Novel Ultrasound Imaging Agent: Two Phase 3 International Trials in Comparison with Radionuclide Perfusion Imaging.” European Journal of Echocardiography 10 (1): 26–35. doi:10.1093/ejechocard/jen321.